• 2024 ICH Guideline Reveals: Essential CMC and Drug Development Insights

  • Nov 12 2024
  • Length: 27 mins
  • Podcast

2024 ICH Guideline Reveals: Essential CMC and Drug Development Insights

Listen for free

View show details

  • Summary

  • The podcast discusses the International Council for Harmonisation (ICH) guidelines and their impact on pharmaceutical development. Specifically, the text focuses on the key updates to the ICH guidelines, including Q2(R2)/Q14 for analytical validation, Q5(R2) for viral safety evaluation, and Q9(R1) for quality risk management. The text also examines the ICH's efforts to address emerging technologies in cell and gene therapy and real-world data utilization for safety assessments. Finally, the text discusses the impact of the ICH Biannual Assembly held in June 2024, including progress updates on current guidelines, the introduction of new proposals, and the harmonization of regulatory requirements across different regions.

    Support the show
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 2024 ICH Guideline Reveals: Essential CMC and Drug Development Insights

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available